Protalix BioTherapeutics Inc. (DE) Company Profile
NYSE: PLXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.71-0.02 (-0.73%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Protalix BioTherapeutics (DE) at a glance
Protalix BioTherapeutics Inc. (DE) (NYSE: PLX) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. At a market capitalization of $220.0 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001006281, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Protalix BioTherapeutics Inc. (DE)
- Ticker
- NYSE: PLX
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- Israel
- Market cap
- $219.96M
- SEC CIK
- 0001006281
Companies similar to Protalix BioTherapeutics (DE)
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| IVVDInvivyd Inc. | 0.7286 | -9.65% | $214.76M | vs PLX |
| ALECAlector Inc. | 1.92 | +6.08% | $214.38M | vs PLX |
| IPSCCentury Therapeutics Inc. | 1.28 | -3.03% | $231.78M | vs PLX |
| CGENCompugen Ltd. | 2.15 | -3.15% | $203.66M | vs PLX |
| LCTXLineage Cell Therapeutics Inc. | 0.9476 | +1.03% | $239.66M | vs PLX |
| STROSutro Biopharma Inc. | 14.66 | +1.45% | $243.08M | vs PLX |
| CMPXCompass Therapeutics Inc. | 1.02 | +2.19% | $183.69M | vs PLX |
| FATEFate Therapeutics Inc. | 2.15 | -6.11% | $257.61M | vs PLX |